Whooping Cough, FDA approves Kyprolis, Sleep and Nursing Homes
|Updated: 7/20/2012 5:41 pm
||Published: 7/20/2012 4:38 pm
A highly-contagious illness that often infects infants is making a comeback in 2012.
The CDC says nearly 18-hundred cases of Pertussis, or whooping cough, have been reported this year.
That's the highest rate in five years, and more than double last year's numbers.
Whooping cough can cause potentially-fatal eating, drinking and breathing problems.
It can be prevented with a vaccine.
FDA approves Kyprolis
The FDA approved Kyprolis for people with multiple myeloma who have already tried at least two treatments for the blood cancer.
The intravenous drug was approved based on a study of more than 266 patients.
Most common side effects were fatigue, low blood cell count and blood
The drug was approved under accelerated approval program.
It allows the FDA to approve a drug based on clinical data showing its reasonable effectiveness.
The company must submit additional clinical information after approval to confirm the drug's benefit.
Sleep and Nursing Homes
Not getting a good night's sleep may predict whether you'll end up in a nursing home or assisted living facility.
Johns Hopkins researchers studied a group of elderly women.
Participants wore devices that recorded their sleeping and waking patterns.
Results show women who spent the most time awake after first falling asleep were about three times more likely to end up in a nursing home or personal care facility.
Findings appear in the journal of the American Geriatrics Society.
Copyright 2012 Newport Television LLC All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.